divendres, 22 d’agost del 2014

Allergan can't delay shareholder vote on hostile Valeant bid




Valeant Pharmaceuticals and Pershing Square Capital Management reportedly plan to ask Allergan for a shareholder vote on their hostile takeover attempt, after a federal judge rules that Allergan's insider trading lawsuit won't delay the meeting.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/YISIo7

Cap comentari:

Publica un comentari a l'entrada